Friedrich Horak

Overview

Best Publications

• Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs

  J. Bousquet;H. J. Schünemann;B. Samolinski;P. Demoly

  7892
  Citations

• Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis.

  Alain Didier;Hans-Jörgen Malling;Margitta Worm;Friedrich Horak

  654
  Citations

• Vaccination with genetically engineered allergens prevents progression of allergic disease

  V. Niederberger;F. Horak;S. Vrtala;S. Spitzauer

  476
  Citations

• Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis

  Gabrielle Pauli;Tina H. Larsen;Sabina Rak;Friedrich Horak

  398
  Citations

• A well‐tolerated grass pollen‐specific allergy vaccine containing
a novel adjuvant, monophosphoryl lipid A, reduces allergic symptoms after only four preseasonal injections

  Unknown

  290
  Citations

• MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation

  J. Bousquet;H. J. Schunemann;J. Fonseca;B. Samolinski

  282
  Citations

• Component-resolved diagnosis of house-dust mite allergy with purified natural and recombinant mite allergens.

  G. Pittner;S. Vrtala;W. R. Thomas;M. Weghofer

  242
  Citations

• Identification of Der p 23, a Peritrophin-like Protein, as a New Major Dermatophagoides pteronyssinus Allergen Associated with the Peritrophic Matrix of Mite Fecal Pellets

  Margit Weghofer;Monika Grote;Yvonne Resch;Anne Casset

  234
  Citations

• Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen-induced rhinoconjunctivitis.

  Alain Didier;Margitta Worm;Friedrich Horak;Gordon Sussman

  228
  Citations

• MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis

  Jean Bousquet;Holger J. Schünemann;Peter W. Hellings;Sylvie Arnavielhe

  226
  Citations

• ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

  J Bousquet;P W Hellings;I Agache;A Bedbrook

  224
  Citations

• Allergen-specific nasal IgG antibodies induced by vaccination with genetically modified allergens are associated with reduced nasal allergen sensitivity

  Jürgen Reisinger;Friedrich Horak;Gabrielle Pauli;Marianne van Hage

  217
  Citations

• A Th17- and Th2-skewed cytokine profile in cystic fibrosis lungs represents a potential risk factor for Pseudomonas aeruginosa infection.

  Kerstin Tiringer;Angela Treis;Petra Fucik;Mia Gona

  213
  Citations

• Early onset of action of a 5-grass-pollen 300-IR sublingual immunotherapy tablet evaluated in an allergen challenge chamber.

  Friedrich Horak;Petra Zieglmayer;René Zieglmayer;Patrick Lemell

  207
  Citations

• Onset and dose-related efficacy of house dust mite sublingual immunotherapy tablets in an environmental exposure chamber.

  Hendrik Nolte;Jennifer Maloney;Harold S. Nelson;David I. Bernstein

  200
  Citations

• Systemic Immunological Changes Induced by Administration of Grass Pollen Allergens via the Oral Mucosa during Sublingual Immunotherapy

  C. Fanta;B. Bohle;W. Hirt;U. Siemann

  188
  Citations

• Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis - A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement

  Peter Hellings;Peter Hellings;W J Fokkens;C Bachert;C Bachert;C A Akdis

  186
  Citations

• Clinical effects of immunotherapy with genetically modified recombinant birch pollen Bet v 1 derivatives

  A. Purohit;V. Niederberger;M. Kronqvist;F. Horak

  186
  Citations

• Acute effects of particulate matter on respiratory diseases, symptoms and functions:: epidemiological results of the Austrian Project on Health Effects of Particulate Matter (AUPHEP)

  Manfred Neuberger;Michael G Schimek;Friedrich Horak;Hanns Moshammer

  175
  Citations

• A regulatory dendritic cell signature correlates with the clinical efficacy of allergen-specific sublingual immunotherapy.

  Aline Zimmer;Julien Bouley;Maxime Le Mignon;Elodie Pliquet

  173
  Citations

• Ultrashort-specific immunotherapy successfully treats seasonal allergic rhinoconjunctivitis to grass pollen.

  Lawrence M. DuBuske;Anthony J. Frew;Friedrich Horak;Paul K. Keith

  156
  Citations

• Effect of desloratadine versus placebo on nasal airflow and subjective measures of nasal obstruction in subjects with grass pollen-induced allergic rhinitis in an allergen-exposure unit.

  Friedrich Horak;Ursula P. Stübner;Rene Zieglmayer;Alan G. Harris

  155
  Citations